{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T02:01:52Z","timestamp":1775440912105,"version":"3.50.1"},"reference-count":129,"publisher":"Frontiers Media SA","issue":"7","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1111\/tri.13160","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T05:10:13Z","timestamp":1522732213000},"page":"689-699","source":"Crossref","is-referenced-by-count":19,"title":["Cardiovascular disease after transplantation: an emerging role of the immune system"],"prefix":"10.3389","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7628-8491","authenticated-orcid":false,"given":"Steven","family":"Van Laecke","sequence":"first","affiliation":[{"name":"Renal Division; Ghent University Hospital; Ghent Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Malfait","sequence":"additional","affiliation":[{"name":"Renal Division; Ghent University Hospital; Ghent Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Schepers","sequence":"additional","affiliation":[{"name":"Renal Division; Ghent University Hospital; Ghent Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[{"name":"Renal Division; Ghent University Hospital; Ghent Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"10.1111\/tri.13160-BIB0001|tri13160-cit-0001","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gistera","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/tri.13160-BIB0002|tri13160-cit-0002","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","article-title":"Role of the immune system in hypertension","volume":"97","author":"Rodriguez-Iturbe","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1111\/tri.13160-BIB0003|tri13160-cit-0003","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/TP.0b013e3181ce243f","article-title":"Cardiovascular disease in kidney transplant recipients: the prognostic value of inflammatory cytokine genotypes","volume":"89","author":"La Manna","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0004|tri13160-cit-0004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/cei.12477","article-title":"The role of T and B cells in human atherosclerosis and atherothrombosis","volume":"179","author":"Ammirati","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/tri.13160-BIB0005|tri13160-cit-0005","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0963689717735404","article-title":"Post-transplant immune activation: innocent bystander or insidious culprit of post-transplant accelerated atherosclerosis","volume":"26","author":"Ducloux","year":"2017","journal-title":"Cell Transplant"},{"key":"10.1111\/tri.13160-BIB0006|tri13160-cit-0006","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.103.11.1509","article-title":"Molecular fingerprint of interferon-gamma signaling in unstable angina","volume":"103","author":"Liuzzo","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/tri.13160-BIB0007|tri13160-cit-0007","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/TP.0b013e318282f2b1","article-title":"Association of single nucleotide polymorphisms on chromosome 9p21.3 with cardiovascular death in kidney transplant recipients","volume":"95","author":"Melk","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0008|tri13160-cit-0008","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature09753","article-title":"9p21 DNA variants associated with coronary artery disease impairs interferon-\u03b3 signaling response","volume":"470","author":"Harismendy","year":"2011","journal-title":"Nature"},{"key":"10.1111\/tri.13160-BIB0009|tri13160-cit-0009","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.atherosclerosis.2010.01.004","article-title":"Is inflammation prior to transplantation predictive for cardiovascular and renal outcomes?","volume":"210","author":"Kr\u00fcger","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1111\/tri.13160-BIB0010|tri13160-cit-0010","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/ajt.12834","article-title":"Understanding the CD28\/CTLA-4 (CD152) pathway and its implications for costimulatory blockade","volume":"14","author":"Gartner","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0011|tri13160-cit-0011","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ijcard.2012.12.085","article-title":"T-cell co-stimulation by CD28-CD80\/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development","volume":"168","author":"Ewing","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1111\/tri.13160-BIB0012|tri13160-cit-0012","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/ATVBAHA.114.303568","article-title":"Treating atherosclerosis with regulatory T cells","volume":"35","author":"Foks","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/tri.13160-BIB0013|tri13160-cit-0013","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/ATVBAHA.115.306848","article-title":"Overexpression of cytotoxic T-lymphocyte-associated antigen-4 prevents atherosclerosis in mice","volume":"36","author":"Matsumoto","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/tri.13160-BIB0014|tri13160-cit-0014","article-title":"Immune checkpoint inhibitors and cardiac toxicity: an emerging issue","author":"Varricchi","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1111\/tri.13160-BIB0015|tri13160-cit-0015","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.jacc.2016.08.036","article-title":"Adaptive immunity dysregulation in acute coronary syndromes","volume":"68","author":"Flego","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/tri.13160-BIB0016|tri13160-cit-0016","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/imm.12506","article-title":"The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases","volume":"146","author":"Dumitriu","year":"2015","journal-title":"Immunology"},{"key":"10.1111\/tri.13160-BIB0017|tri13160-cit-0017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/acel.12552","article-title":"Phenotypic characteristics of aged CD4+ CD28null T lymphocytes are determined by changes in the whole-genome DNA methylation pattern","volume":"16","author":"Suarez-Alvarez","year":"2017","journal-title":"Ageing Cell"},{"key":"10.1111\/tri.13160-BIB0018|tri13160-cit-0018","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jacc.2007.06.040","article-title":"Unusual CD4+ CD28null T lymphocytes and recurrence of acute coronary events","volume":"50","author":"Liuzzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/tri.13160-BIB0019|tri13160-cit-0019","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.atherosclerosis.2013.08.008","article-title":"CD4+CD28null cells are an independent predictor of mortality in patients with heart failure","volume":"230","author":"Koller","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1111\/tri.13160-BIB0020|tri13160-cit-0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1160\/TH16-07-0531","article-title":"The impact of CD4+CD28null T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure","volume":"117","author":"Sulzgruber","year":"2017","journal-title":"Thromb Haemostasis"},{"key":"10.1111\/tri.13160-BIB0021|tri13160-cit-0021","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/ajt.13614","article-title":"Cytomegalovirus-associated CD4+ CD28 null cells in NKG2D-dependent glomerular endothelial injury and kidney allograft dysfunction","volume":"16","author":"Shabir","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0022|tri13160-cit-0022","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/ajt.13351","article-title":"Hyperlipidemia alters regulatory T cell function and promotes resistance to tolerance induction through costimulatory molecule blockade","volume":"15","author":"Bagley","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0023|tri13160-cit-0023","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1093\/ndt\/gfq203","article-title":"Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients","volume":"25","author":"Betjes","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.13160-BIB0024|tri13160-cit-0024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.humimm.2012.08.001","article-title":"Prevalence of circulating CD4+CD28null T cells is associated with early atherosclerotic damage in patients with end-stage renal disease undergoing hemodialysis","volume":"74","author":"Sun","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1111\/tri.13160-BIB0025|tri13160-cit-0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000338352","article-title":"Cytotoxic CD4+CD28null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease","volume":"120","author":"Yadav","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1111\/tri.13160-BIB0026|tri13160-cit-0026","doi-asserted-by":"crossref","first-page":"841430","DOI":"10.1155\/2013\/841430","article-title":"Circulation CD4+CD28null T cells may increase the risk of an atherosclerotic vascular event shortly after kidney transplantation","volume":"2013","author":"Betjes","year":"2013","journal-title":"J Transplant"},{"key":"10.1111\/tri.13160-BIB0027|tri13160-cit-0027","doi-asserted-by":"crossref","first-page":"e0150826","DOI":"10.1371\/journal.pone.0150826","article-title":"Loss of CD28 on peripheral T cells decreases the risk for early acute rejection after kidney transplantation","volume":"11","author":"Dedeoglu","year":"2016","journal-title":"PLoS One"},{"key":"10.1111\/tri.13160-BIB0028|tri13160-cit-0028","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ajt.14480","article-title":"CD4+ CD2null T cells are not alloreactive unless stimulated by interleukin-15","volume":"18","author":"Dedeoglu","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0029|tri13160-cit-0029","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00296-016-3643-8","article-title":"CD4+CD28null T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis","volume":"37","author":"Slot","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1111\/tri.13160-BIB0030|tri13160-cit-0030","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/TP.0000000000000641","article-title":"Impact of cytomegalovirus on long-term mortality and cancer risk after organ transplantation","volume":"99","author":"Desai","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0031|tri13160-cit-0031","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.TP.0000435697.31148.b2","article-title":"Substantial proliferation of human renal tubular epithelial cell-reactive CD4+ CD28null memory T cells, which is resistant to tacrolimus and everolimus","volume":"97","author":"Demmers","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0032|tri13160-cit-0032","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fimmu.2017.00195","article-title":"Expansions of cytotoxic CD4+ CD28- T cells drive excess cardiovascular mortality in rheumatoid arthritis and other chronic inflammatory conditions and are triggered by CMV infection","volume":"8","author":"Broadley","year":"2017","journal-title":"Front Immunol"},{"key":"10.1111\/tri.13160-BIB0033|tri13160-cit-0033","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jamadermatol.2016.1984","article-title":"Association between changes in coronary artery disease progression and treatment with biologic agents for severe psoriasis","volume":"152","author":"Hjuler","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1111\/tri.13160-BIB0034|tri13160-cit-0034","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13160-BIB0035|tri13160-cit-0035","first-page":"CD005019","article-title":"HMG CoA reductase inhibitors (statins) for kidney transplant recipients","volume":"28","author":"Palmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/tri.13160-BIB0036|tri13160-cit-0036","doi-asserted-by":"crossref","first-page":"167086","DOI":"10.1155\/2013\/167086","article-title":"Statins as modulators of regulatory T-cell biology","volume":"2013","author":"Forero-Pena","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1111\/tri.13160-BIB0037|tri13160-cit-0037","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00392-010-0225-8","article-title":"Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes","volume":"100","author":"Link","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1111\/tri.13160-BIB0038|tri13160-cit-0038","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/eji.200838863","article-title":"Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation","volume":"39","author":"Raemer","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1111\/tri.13160-BIB0039|tri13160-cit-0039","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/eurheartj\/ehq499","article-title":"Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus","volume":"32","author":"Giubilato","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1111\/tri.13160-BIB0040|tri13160-cit-0040","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13160-BIB0041|tri13160-cit-0041","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI63891","article-title":"Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis","volume":"123","author":"Klingenberg","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1111\/tri.13160-BIB0042|tri13160-cit-0042","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3324\/haematol.2015.128934","article-title":"Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells","volume":"101","author":"Scotta","year":"2016","journal-title":"Haematologica"},{"key":"10.1111\/tri.13160-BIB0043|tri13160-cit-0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3182590d8f","article-title":"In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function","volume":"94","author":"Miroux","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0044|tri13160-cit-0044","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1111\/j.1600-6143.2012.04269.x","article-title":"Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients","volume":"12","author":"Akimova","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0045|tri13160-cit-0045","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2004.07.014","article-title":"Glucocorticosteroids upregulate FOXP3 expression and regulatory T cells in asthma","volume":"114","author":"Karagiannidis","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/tri.13160-BIB0046|tri13160-cit-0046","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/TP.0b013e31819d2032","article-title":"Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells","volume":"87","author":"Demirkiran","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0047|tri13160-cit-0047","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fimmu.2017.00219","article-title":"Methylation of FOXP3 TSDR underlies the impaired suppressive function of Tregs from long-term belatacept-treated kidney transplant patients","volume":"8","author":"Alvarez Salazar","year":"2017","journal-title":"Front Immunol"},{"key":"10.1111\/tri.13160-BIB0048|tri13160-cit-0048","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/TP.0b013e31829f1607","article-title":"Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans","volume":"96","author":"Levitsky","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0049|tri13160-cit-0049","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ki.2010.533","article-title":"Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients","volume":"79","author":"Tsaur","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13160-BIB0050|tri13160-cit-0050","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1172\/JCI46028","article-title":"IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-\/- mice","volume":"121","author":"Wang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1111\/tri.13160-BIB0051|tri13160-cit-0051","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.kint.2016.03.019","article-title":"Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity","volume":"90","author":"Dragun","year":"2016","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13160-BIB0052|tri13160-cit-0052","doi-asserted-by":"crossref","first-page":"13411","DOI":"10.1038\/srep13411","article-title":"Parity and cardiovascular disease mortality: a dose-response meta-analysis of cohort studies","volume":"5","author":"Lv","year":"2015","journal-title":"Sci Rep"},{"key":"10.1111\/tri.13160-BIB0053|tri13160-cit-0053","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jama.2017.14825","article-title":"Association of blood transfusion from female donors with and without a history of pregnancy with mortality among male and female transfusion recipients","volume":"318","author":"Caram-Deelder","year":"2017","journal-title":"JAMA"},{"key":"10.1111\/tri.13160-BIB0054|tri13160-cit-0054","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.exphem.2012.06.003","article-title":"Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens","volume":"40","author":"Detrait","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1111\/tri.13160-BIB0055|tri13160-cit-0055","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1681\/ASN.2014090894","article-title":"Immune sensitization and mortality in wait-listed kidney transplant candidates","volume":"27","author":"Sapir-Pichhadze","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13160-BIB0056|tri13160-cit-0056","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.13661","article-title":"Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin","volume":"15","author":"Beland","year":"2017","journal-title":"J Thromb Haemostasis"},{"key":"10.1111\/tri.13160-BIB0057|tri13160-cit-0057","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCRESAHA.117.306340","article-title":"Determinants and outcomes of accelerated arteriosclerosis: major impact of circulating antibodies","volume":"117","author":"Loupy","year":"2015","journal-title":"Circ Res"},{"key":"10.1111\/tri.13160-BIB0058|tri13160-cit-0058","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/ajt.13644","article-title":"HLA class II antibody activation of endothelial cells promotes Th17 and disrupts regulatory T lymphocyte expansion","volume":"16","author":"Lion","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0059|tri13160-cit-0059","first-page":"S221","article-title":"Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. Sandoz\/CVIS investigators","volume":"14","author":"Kobashigawa","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0060|tri13160-cit-0060","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/CIRCULATIONAHA.116.022907","article-title":"Gene expression profiling for the identification and classification of antibody-mediated heart rejection","volume":"135","author":"Loupy","year":"2017","journal-title":"Circulation"},{"key":"10.1111\/tri.13160-BIB0061|tri13160-cit-0061","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.healun.2015.08.008","article-title":"Donor-specific HLA alloantibodies: impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation","volume":"35","author":"Tran","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0062|tri13160-cit-0062","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.healun.2007.05.008","article-title":"Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy","volume":"26","author":"Raichlin","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0063|tri13160-cit-0063","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.trre.2016.01.001","article-title":"Statin therapy in cardiac allograft vasculopathy progression in heart transplant patients: does potency matter?","volume":"30","author":"Sieg","year":"2016","journal-title":"Transplant Rev"},{"key":"10.1111\/tri.13160-BIB0064|tri13160-cit-0064","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13160-BIB0065|tri13160-cit-0065","doi-asserted-by":"crossref","first-page":"e003265","DOI":"10.1161\/CIRCHEARTFAILURE.116.003265","article-title":"Impact of statin use after heart transplantation: a meta-analysis","volume":"9","author":"Vallakati","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1111\/tri.13160-BIB0066|tri13160-cit-0066","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.amjcard.2004.09.035","article-title":"Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry","volume":"95","author":"Wu","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1111\/tri.13160-BIB0067|tri13160-cit-0067","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/TP.0b013e318264d3ef","article-title":"Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival","volume":"94","author":"Wolf","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0068|tri13160-cit-0068","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/TP.0000000000001853","article-title":"Non-HLA antibodies impact on C4d staining, stellate cell activation and fibrosis in liver allografts","volume":"101","author":"O'Leary","year":"2017","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0069|tri13160-cit-0069","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/ctr.12851","article-title":"Preformed donor-specific HLA antibodies are associated with increased risk of early mortality after liver transplantation","volume":"30","author":"McCaughan","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.13160-BIB0070|tri13160-cit-0070","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/ajt.12147","article-title":"Class II alloantibody and mortality in simultaneous liver-kidney transplantation","volume":"13","author":"O'Leary","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0071|tri13160-cit-0071","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.13153","article-title":"Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation","volume":"15","author":"O'Leary","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0072|tri13160-cit-0072","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/lt.24100","article-title":"Evolution of serum atherogenic risk in liver transplant recipients: role of lipoproteins and metabolic and inflammatory markers","volume":"21","author":"Chhatrala","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.13160-BIB0073|tri13160-cit-0073","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.3748\/wjg.v20.i26.8667","article-title":"Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation","volume":"20","author":"Alvares-da-Silva","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/tri.13160-BIB0074|tri13160-cit-0074","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/lt.23880","article-title":"Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events","volume":"20","author":"Watt","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.13160-BIB0075|tri13160-cit-0075","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.12-0587","article-title":"Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients","volume":"144","author":"Snyder","year":"2013","journal-title":"Chest"},{"key":"10.1111\/tri.13160-BIB0076|tri13160-cit-0076","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.healun.2014.07.018","article-title":"De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation","volume":"33","author":"Morrell","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0077|tri13160-cit-0077","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.healun.2014.07.012","article-title":"De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation","volume":"33","author":"Safavi","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0078|tri13160-cit-0078","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/TP.0b013e31827afb0f","article-title":"Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay","volume":"95","author":"Brugi\u00e8re","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0079|tri13160-cit-0079","doi-asserted-by":"crossref","first-page":"1701248","DOI":"10.1183\/13993003.01248-2017","article-title":"Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation","volume":"50","author":"Verleden","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1111\/tri.13160-BIB0080|tri13160-cit-0080","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2012.04.007","article-title":"Bronchiolitis obliterans syndrome is associated with increased peripheral blood natural killer and natural killer T-like granzymes, perforin, and T-helper-type 1 pro-inflammatory cytokines","volume":"31","author":"Hodge","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0081|tri13160-cit-0081","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cei.12081","article-title":"Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome","volume":"173","author":"Hodge","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/tri.13160-BIB0082|tri13160-cit-0082","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.healun.2011.11.008","article-title":"Effect of simvastatin on development of obliterative airway disease: an experimental study","volume":"31","author":"Ropponen","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0083|tri13160-cit-0083","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/acel.12430","article-title":"CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study","volume":"15","author":"Spyridopoulos","year":"2016","journal-title":"Aging Cell"},{"key":"10.1111\/tri.13160-BIB0084|tri13160-cit-0084","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwq177","article-title":"Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up","volume":"172","author":"Roberts","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1111\/tri.13160-BIB0085|tri13160-cit-0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00007890-200007270-00013","article-title":"Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease","volume":"70","author":"Humar","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0086|tri13160-cit-0086","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s12879-015-1321-1","article-title":"Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients","volume":"15","author":"Johansson","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1111\/tri.13160-BIB0087|tri13160-cit-0087","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.healun.2015.03.015","article-title":"Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation","volume":"34","author":"Delgado","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0088|tri13160-cit-0088","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jit064","article-title":"Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients","volume":"207","author":"Courivaud","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1111\/tri.13160-BIB0089|tri13160-cit-0089","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/infdis\/jis276","article-title":"Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women","volume":"205","author":"Parrinello","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1111\/tri.13160-BIB0090|tri13160-cit-0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trre.2014.01.001","article-title":"The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients","volume":"28","author":"Roman","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1111\/tri.13160-BIB0091|tri13160-cit-0091","doi-asserted-by":"crossref","first-page":"e1005832","DOI":"10.1371\/journal.ppat.1005832","article-title":"Cytomegalovirus infection leads to development of high frequencies of cytotoxic virus-specific CD4+ T cells targeted to vascular endothelium","volume":"12","author":"Pachnio","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1111\/tri.13160-BIB0092|tri13160-cit-0092","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.2013060663","article-title":"Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients","volume":"25","author":"Ducloux","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13160-BIB0093|tri13160-cit-0093","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/TP.0000000000000522","article-title":"Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients","volume":"99","author":"Opelz","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0094|tri13160-cit-0094","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","article-title":"Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study","volume":"100","author":"Valantine","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/tri.13160-BIB0095|tri13160-cit-0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.healun.2009.02.009","article-title":"Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients","volume":"28","author":"Potena","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.13160-BIB0096|tri13160-cit-0096","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cpt.738","article-title":"Negative cardiovascular consequences of small molecule immunosuppressants","volume":"102","author":"Chakkera","year":"2017","journal-title":"Clin Pharmcol Ther"},{"key":"10.1111\/tri.13160-BIB0097|tri13160-cit-0097","first-page":"CD005632","article-title":"Steroid avoidance or withdrawal for kidney transplant recipients","volume":"22","author":"Haller","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/tri.13160-BIB0098|tri13160-cit-0098","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/tri.13160-BIB0099|tri13160-cit-0099","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1111\/tri.13160-BIB0100|tri13160-cit-0100","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.1038\/ncomms14680","article-title":"T cell costimulation blockade blunts pressure overload-induced heart failure","volume":"8","author":"Kallikourdis","year":"2017","journal-title":"Nat Commun"},{"key":"10.1111\/tri.13160-BIB0101|tri13160-cit-0101","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vicenti","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13160-BIB0102|tri13160-cit-0102","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10067-009-1095-1","article-title":"Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis","volume":"28","author":"Kerekes","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1111\/tri.13160-BIB0103|tri13160-cit-0103","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jcpt.12522","article-title":"Anterior ST-elevation myocardial infarction induced by rituximab infusion: a case report and review of the literature","volume":"42","author":"Sharif","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/tri.13160-BIB0104|tri13160-cit-0104","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trre.2014.12.001","article-title":"A systematic review of the use of rituximab as induction therapy in renal transplantation","volume":"29","author":"Macklin","year":"2015","journal-title":"Transplant Rev"},{"key":"10.1111\/tri.13160-BIB0105|tri13160-cit-0105","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell depleting induction therapy and acute cellular rejection","volume":"360","author":"Clatworthy","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1111\/tri.13160-BIB0106|tri13160-cit-0106","first-page":"403","article-title":"Rituximab induction in cardiac transplantation is associated with accelerated coronary artery vasculopathy: CTOT11","volume":"16","author":"Chandraker","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0107|tri13160-cit-0107","doi-asserted-by":"crossref","first-page":"e27987","DOI":"10.4161\/onci.27987","article-title":"Adverse cardiac events to monoclonal antibodies used for cancer therapy: the risk of Kounis syndrome","volume":"3","author":"Kounis","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1111\/tri.13160-BIB0108|tri13160-cit-0108","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.113.301145","article-title":"B cells and humoral immunity in atherosclerosis","volume":"114","author":"Tsiantoulas","year":"2014","journal-title":"Circ Res"},{"key":"10.1111\/tri.13160-BIB0109|tri13160-cit-0109","doi-asserted-by":"crossref","first-page":"e33939","DOI":"10.1371\/journal.pone.0033939","article-title":"Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28-T cells","volume":"7","author":"Duftner","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/tri.13160-BIB0110|tri13160-cit-0110","first-page":"1601","article-title":"Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects","volume":"32","author":"Bamoulid","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.13160-BIB0111|tri13160-cit-0111","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2215\/CJN.03180509","article-title":"Immunosuppressive drugs and Tregs: a critical evaluation!","volume":"4","author":"De Serres","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.13160-BIB0112|tri13160-cit-0112","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/TP.0000000000000869","article-title":"The influence of immunosuppressive agents on the risk of de novo donor-specific HLA antibody production in solid organ transplant recipients","volume":"100","author":"O'Leary","year":"2016","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0113|tri13160-cit-0113","doi-asserted-by":"crossref","first-page":"e002252","DOI":"10.1161\/CIRCHEARTFAILURE.115.002252","article-title":"Induction therapy with antithymocyte globulin in patients undergoing cardiac transplantation is associated with decreased coronary plaque progression as assessed by intravascular ultrasound","volume":"9","author":"Azarbal","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1111\/tri.13160-BIB0114|tri13160-cit-0114","doi-asserted-by":"crossref","first-page":"27915","DOI":"10.1038\/srep27915","article-title":"Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling","volume":"6","author":"Rodrigues-Diez","year":"2016","journal-title":"Sci Rep"},{"key":"10.1111\/tri.13160-BIB0115|tri13160-cit-0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/TP.0b013e3182958552","article-title":"Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients","volume":"96","author":"Mourer","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0116|tri13160-cit-0116","first-page":"CD006750","article-title":"Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients","volume":"7","author":"Karpe","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/tri.13160-BIB0117|tri13160-cit-0117","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2010.01.043","article-title":"Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis","volume":"211","author":"Van Leuven","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1111\/tri.13160-BIB0118|tri13160-cit-0118","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.tp.0000248864.21574.92","article-title":"Mycophenolate mofetil and C-reactive protein in renal transplant recipients","volume":"83","author":"Wong","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0119|tri13160-cit-0119","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/lt.24738","article-title":"Cardiovascular morbidity and mortality after liver transplantation: the protective role of mycophenolate mofetil","volume":"23","author":"D'Avola","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.13160-BIB0120|tri13160-cit-0120","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1600-6143.2006.01297.x","article-title":"Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0121|tri13160-cit-0121","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0122|tri13160-cit-0122","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1097\/TP.0000000000001432","article-title":"Recent advances in mammalian target of rapamycin inhibitor use in heart and lung transplantation","volume":"100","author":"Fine","year":"2016","journal-title":"Transplantation"},{"key":"10.1111\/tri.13160-BIB0123|tri13160-cit-0123","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/ajt.13214","article-title":"The effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo recipients: one-year results of a Scandinavian randomized trial","volume":"15","author":"Arora","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0124|tri13160-cit-0124","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/tri.12413","article-title":"Cardiovascular morbidity and mortality after kidney transplantation","volume":"28","author":"Stoumpos","year":"2015","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13160-BIB0125|tri13160-cit-0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-6143.2012.04281.x","article-title":"Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation","volume":"13","author":"Isakova","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13160-BIB0126|tri13160-cit-0126","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1111\/tri.13160-BIB0127|tri13160-cit-0127","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2014.350","article-title":"Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus","volume":"87","author":"Gallon","year":"2015","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13160-BIB0128|tri13160-cit-0128","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/eji.200838761","article-title":"Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells","volume":"38","author":"Schmitz","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1111\/tri.13160-BIB0129|tri13160-cit-0129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/tri.12975","article-title":"mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now?","volume":"30","author":"Grimbert","year":"2017","journal-title":"Transpl Int"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.13160","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.13160\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T21:21:02Z","timestamp":1660771262000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.13160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":129,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.13160","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,30]]}}}